Inflammatory bowel disease
On behalf of the Journal of inflammatory bowel disease and disorders, as Editor-in-Chief, it is my distinct honour and privilege to inform you that, it’s been four long years we have started the Journal, now we are celebrating the 04th Anniversary and we are privileged to welcome Analytical Society to our journal. As Editor-In-Chief it is my great pleasure and honour to welcome you to the Journal of inflammatory bowel disease and disorders
Inflammatory colitis, Crohns disease and Ulcerative colitis are classified under inflammatory bowel disease (IBD), which is a complex group of inflammatory conditions. Where in patients require both induction and lifelong medication. The interaction between genetic factors and the environment causes IBD, and inflammatory gut diseases can be caused by modifications to enteral bacteria.
The Journal of inflammatory bowel disease and disorders aims to disseminate knowledge and promote discussion through the publication of peer-reviewed, high quality research papers on all topics related to Chromatography. The open access journal is published by OMICS International who hosts around 350 open access peer-reviewed journals as well as organizes more than 100 International scientific Conferences.
The Journal is successfully running in the 04th Volume which covers a wide variety of specialties including pharmaceutical and clinical sciences, reaching out to analytical scientists worldwide. The Journal emphasizes high-level research and education. Original research articles, reviews, short communications, and letters to the editors in the fields of chromatography and separation are welcome. Every effort is made to have a speedy and critical peer-review process.
Realizing the importance of this field, OMICS Group has organized a prestigious conference on 16th World Congress on Gastroenterology & Therapeutics scheduled to be held during April 06-07, 2020 at Osaka, Japan. under the theme ‘Providing a global platform to explore and enhance the future of medicine and pharmaceutical biotechnology.
The conference includes around 150Abstracts and 100 Keynote speakers have given their valuable words. The meet has provided a great scope for interaction of professionals including in addition to clinical experts and top-level pathologists and scientists from around the globe, on a single platform.